NYSE$HLF
Herbalife Nutrition Ltd. · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Herbalife Nutrition reported a decrease in net sales but exceeded adjusted EPS and EBITDA guidance.
Herbalife Nutrition reported Q3 2021 financial results with net sales of $1.4 billion, a 6% decrease compared to Q3 2020, but in line with guidance. Diluted EPS was $1.09, and adjusted diluted EPS was $1.21. The company exceeded the high-end of its guidance range for adjusted diluted EPS and adjusted EBITDA and is reiterating its FY 2021 outlook.
- Net sales were $1.4 billion, a 6% decrease compared to the prior year, but in-line with guidance.
- Reported diluted EPS was $1.09, and adjusted diluted EPS was $1.21, both increasing by approximately 5% compared to the prior year.
- The company exceeded the high-end of its guidance range for adjusted diluted EPS and adjusted EBITDA.
- Asia Pacific led with double-digit net sales growth, up 11% compared to the prior year.
Headline financials
Revenue & EPS history
Herbalife · Revenue · Quarterly
$1.43B
Forward guidance
The Company is reiterating its outlook for the full year 2021, including net sales growth of 4.5% - 8.5% and adjusted diluted EPS of $4.55 - $4.95.
Tailwinds
- Net sales growth between 4.5% and 8.5%
- Adjusted diluted EPS between $4.55 and $4.95
- Adjusted EBITDA between $860 million and $910 million
- Net sales guidance includes a projected currency tailwind of approximately 200bps
- Adjusted diluted EPS guidance includes a projected currency tailwind of approximately $0.11 per diluted share
Headwinds
- Excludes any future potential Venezuela currency devaluations and associated pricing and inflationary consequences.
- Excludes any future potential ongoing tax effects from the exercise or vesting of equity awards that could impact the Company's tax rate due to the stock compensation accounting standard.
- Excludes benefits from future potential China grant income.
- Excludes any future potential dilution from the Company’s convertible notes due in 2024, as well as any future impact of the China Growth and Impact Investment Program.
- Adjusted diluted EPS and adjusted EBITDA guidance are non-GAAP measures and exclude potential charges or gains that may be recorded during the applicable period.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
+2.4%
Avg return
Earnings day
+0.3%
Avg return
5 days after
-1.5%
Avg return
30 days after
53%
36 / 68 earnings
Positive
+42.7%
Q4 2024
Best reaction
-31.9%
Q4 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +4.2% | -17.2% | -30.7% | |
| Q4 2025 | +18.3% | +18.5% | -11.1% | |
| Q3 2025 | +10.7% | +10.0% | +48.1% | |
| Q1 2025 | -7.9% | -4.7% | +8.5% | |
| Q4 2024 | +42.7% | +47.5% | +50.0% | |
| Q3 2024 | +8.5% | +18.2% | +11.6% | |
| Q2 2024 | -9.4% | -22.8% | -34.1% | |
| Q1 2024 | +8.4% | +12.4% | +19.1% | |
| Q4 2023 | -31.9% | -31.6% | -24.1% | |
| Q3 2023 | -2.5% | -3.3% | -7.7% | |
| Q2 2023 | +14.8% | +13.3% | -5.7% | |
| Q1 2023 | -8.6% | -6.4% | -20.8% | |
| Q4 2022 | +27.1% | +22.0% | +7.3% | |
| Q3 2022 | -2.8% | -24.5% | -18.5% | |
| Q2 2022 | +12.0% | +13.2% | +7.2% | |
| Q1 2022 | -3.4% | -8.7% | -16.3% | |
| Q4 2021 | -16.7% | -14.5% | -25.8% | |
| Q3 2021 | -3.7% | -5.3% | -17.6% | |
| Q2 2021 | -5.7% | -5.2% | +2.9% | |
| Q1 2021 | +3.2% | +9.1% | +18.0% | |
| Q4 2020 | -10.5% | -18.6% | -17.7% | |
| Q3 2020 | +2.1% | -6.0% | +5.1% | |
| Q2 2020 | -3.4% | -5.2% | -4.6% | |
| Q1 2020 | +22.0% | +16.4% | +35.3% | |
| Q4 2019 | -2.8% | -5.6% | -26.3% | |
| Q3 2019 | +10.6% | +9.4% | +13.0% | |
| Q2 2019 | -7.4% | -6.6% | -16.1% | |
| Q1 2019 | -5.9% | -6.7% | -22.2% | |
| Q4 2018 | -0.9% | -0.6% | -1.0% | |
| Q3 2018 | -1.9% | -1.5% | +4.8% | |
| Q2 2018 | +11.8% | +15.0% | +9.6% | |
| Q1 2018 | +5.1% | +4.6% | -3.9% | |
| Q4 2017 | +3.2% | +4.5% | +18.0% | |
| Q3 2017 | -3.4% | -6.5% | -1.7% | |
| Q2 2017 | -1.9% | -0.9% | +3.8% | |
| Q1 2017 | +11.2% | +16.6% | +18.4% | |
| Q4 2016 | -6.6% | -7.0% | -6.1% | |
| Q3 2016 | -8.6% | -9.4% | -20.5% | |
| Q2 2016 | +1.1% | +0.4% | -8.1% | |
| Q1 2016 | +9.9% | — | — | |
| Q4 2015 | +19.3% | — | — | |
| Q3 2015 | -1.7% | — | — | |
| Q2 2015 | +14.4% | — | — | |
| Q1 2015 | +11.0% | — | — | |
| Q4 2014 | -7.9% | — | — | |
| Q3 2014 | -15.6% | — | — | |
| Q2 2014 | -11.7% | — | — | |
| Q1 2014 | +4.0% | — | — | |
| Q4 2013 | -0.3% | — | — | |
| Q3 2013 | +2.4% | — | — | |
| Q2 2013 | +2.7% | — | — | |
| Q1 2013 | +3.8% | — | — | |
| Q4 2012 | -2.5% | — | — | |
| Q3 2012 | +1.5% | — | — | |
| Q2 2012 | +2.0% | — | — | |
| Q1 2012 | -15.3% | — | — | |
| Q4 2011 | +10.2% | — | — | |
| Q3 2011 | -5.4% | — | — | |
| Q2 2011 | +5.3% | — | — | |
| Q1 2010 | +13.9% | — | — | |
| Q1 2011 | -0.7% | — | — | |
| Q4 2008 | +10.6% | — | — | |
| Q4 2010 | +10.6% | — | — | |
| Q3 2009 | -1.7% | — | — | |
| Q3 2010 | -1.7% | — | — | |
| Q2 2009 | +10.7% | — | — | |
| Q2 2010 | +10.7% | — | — | |
| Q4 2009 | +10.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro